John Romanelli, MD
Surgery · Springfield, MANPI 1396837449
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (35.4%), speaking fees and education — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Intuitive Surgical at 42.8% of the total.
Across 27 payments — averaging $171.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$2K
- ERBE USA Inc$2K
- Ambu Inc.$264
- TELA Bio, Inc.$201
- Cook Medical LLC$145
- Davol Inc.$120
- plus $427 from 8 others
Across 3 payments — averaging $6166.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Davol Inc.$17K
- New View Surgical, Inc.$2K
What the payments were for
- Speaking & faculty fees$1,50032%
- Food & beverage$1,64135%
- Education$1,50032%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 8 | $1,985 |
| ERBE USA Inc | 1 | $1,500 |
| Ambu Inc. | 3 | $264 |
| TELA Bio, Inc. | 2 | $201 |
| Cook Medical LLC | 2 | $145 |
| Davol Inc. | 2 | $120 |
| Boston Scientific | 1 | $118 |
| BD | 1 | $110 |
| Colorado Therapeutics LLC | 1 | $57 |
| Covidien LP | 2 | $47 |
| Medtronic | 1 | $36 |
| New View Surgical, Inc. | 1 | $28 |
| Baxter Healthcare | 1 | $16 |
| Johnson & Johnson | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,641 in reported general payments places this provider in the 70th percentile of 694 surgery providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 15 | $394 |
| Pantoprazole Sodium | 17 | $181 |
Paid to pharmacies, not to this prescriber.
Other surgery in Springfield
- Richard EngelmanSpringfield$167K
- David EarleSpringfield$70K
- Ronald GrossSpringfield$20K
- Michael TarnoffBoston$1.4M
- Omar KudsiBoston$886K
- Philip CohenBrockton$280K
- Ankit MehtaBoston$278K
- Mark ConradMethuen$187K
- James HermenegildoFall River$178K
- Reuben ShinBurlington$158K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.